Clinical trial
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin…
NCT00338104 · Northwestern University, Other · Completed
Key facts
| NCT number | NCT00338104 |
|---|---|
| Title | Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin |
| Official title | Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin |
| Lead sponsor | Northwestern University, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hyperglycemia, Diabetes |
| Intervention type | Drug |
| Interventions | insulin glargine |
| Enrollment | 75 |
| Start date | Jul 1, 2004 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Jun 20, 2006 |
| Last update posted | Apr 6, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: